Synlab AG (LTS:0A9B) Debt-to-Equity : 0.65 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Synlab AG Debt-to-Equity?

Synlab AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €158 Mil. Synlab AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1,388 Mil. Synlab AG's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €2,372 Mil. Synlab AG's debt to equity for the quarter that ended in Mar. 2024 was 0.65.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Synlab AG's Debt-to-Equity or its related term are showing as below:

LTS:0A9B' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.65 Med: 0.86 Max: 2.6
Current: 0.65

During the past 4 years, the highest Debt-to-Equity Ratio of Synlab AG was 2.60. The lowest was 0.65. And the median was 0.86.

LTS:0A9B's Debt-to-Equity is ranked worse than
73.58% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs LTS:0A9B: 0.65

Synlab AG Debt-to-Equity Historical Data

The historical data trend for Synlab AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG Debt-to-Equity Chart

Synlab AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

2.60

0.90

0.91

0.67

Synlab AG Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial											0.85	0.86	0.72	0.67	0.65

Competitive Comparison of Synlab AG's Debt-to-Equity

For the Diagnostics & Research subindustry, Synlab AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synlab AG's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Synlab AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Synlab AG's Debt-to-Equity falls into.

Synlab AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Synlab AG's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(157.269	+	1402.768)	/	2340.398
	=	0.67

Synlab AG's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(157.729	+	1387.795)	/	2371.918
	=	0.65

Synlab AG (LTS:0A9B) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Synlab AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Synlab AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Synlab AG (LTS:0A9B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (LTS:0A9B) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

SYAB:Germany

Address

Moosacher Strasse 88, Augsburg, BY, DEU, 80809

Website

https://www.synlab.de

Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (LTS:0A9B) Headlines

No Headlines